Duopharma Biotech Bhd (7148) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.040x

Based on the latest financial reports, Duopharma Biotech Bhd (7148) has a cash flow conversion efficiency ratio of 0.040x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM30.27 Million ≈ $7.60 Million USD) by net assets (RM757.62 Million ≈ $190.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Duopharma Biotech Bhd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Duopharma Biotech Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Duopharma Biotech Bhd debt and liabilities for a breakdown of total debt and financial obligations.

Duopharma Biotech Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Duopharma Biotech Bhd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Easy Trip Planners Limited NSE:EASEMYTRIP	0.008x
Kneat.com Inc TO:KSI	-0.004x
Shoper S.A. WAR:SHO	0.225x
Sabvest Capital Ltd JSE:SBP	-0.001x
Sunplus Innovation Technology Inc. TWO:5236	0.078x
Koramco Energy Plus Reit Co Ltd KO:357120	0.207x
Eastern Polymer Group Public Company Limited BK:EPG	0.054x
Edda Wind ASA OL:EWIND	0.018x

Annual Cash Flow Conversion Efficiency for Duopharma Biotech Bhd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Duopharma Biotech Bhd from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Duopharma Biotech Bhd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	RM757.62 Million ≈ $190.21 Million	RM112.71 Million ≈ $28.30 Million	0.149x	+28.40%
2024-12-31	RM709.15 Million ≈ $178.04 Million	RM82.16 Million ≈ $20.63 Million	0.116x	+54.42%
2023-12-31	RM687.12 Million ≈ $172.51 Million	RM51.55 Million ≈ $12.94 Million	0.075x	-30.04%
2022-12-31	RM655.22 Million ≈ $164.50 Million	RM70.27 Million ≈ $17.64 Million	0.107x	+54.89%
2021-12-31	RM624.00 Million ≈ $156.67 Million	RM43.20 Million ≈ $10.85 Million	0.069x	-37.52%
2020-12-31	RM643.82 Million ≈ $161.64 Million	RM71.35 Million ≈ $17.91 Million	0.111x	-12.32%
2019-12-31	RM529.75 Million ≈ $133.00 Million	RM66.96 Million ≈ $16.81 Million	0.126x	-15.94%
2018-12-31	RM481.04 Million ≈ $120.77 Million	RM72.33 Million ≈ $18.16 Million	0.150x	+28.73%
2017-12-31	RM479.87 Million ≈ $120.48 Million	RM56.05 Million ≈ $14.07 Million	0.117x	+59.71%
2016-12-31	RM454.52 Million ≈ $114.11 Million	RM33.24 Million ≈ $8.35 Million	0.073x	+164.65%
2015-12-31	RM449.72 Million ≈ $112.91 Million	RM-50.88 Million ≈ $-12.77 Million	-0.113x	-160.89%
2014-12-31	RM193.63 Million ≈ $48.61 Million	RM35.97 Million ≈ $9.03 Million	0.186x	-14.16%
2013-12-31	RM182.65 Million ≈ $45.86 Million	RM39.53 Million ≈ $9.93 Million	0.216x	-4.12%
2012-12-31	RM170.50 Million ≈ $42.81 Million	RM38.49 Million ≈ $9.66 Million	0.226x	+91.65%
2011-12-31	RM164.44 Million ≈ $41.29 Million	RM19.37 Million ≈ $4.86 Million	0.118x	-53.56%
2010-12-31	RM157.87 Million ≈ $39.64 Million	RM40.04 Million ≈ $10.05 Million	0.254x	+33.09%
2009-12-31	RM142.74 Million ≈ $35.84 Million	RM27.20 Million ≈ $6.83 Million	0.191x	-5.97%
2008-12-31	RM130.55 Million ≈ $32.78 Million	RM26.46 Million ≈ $6.64 Million	0.203x	-7.77%
2007-12-31	RM114.21 Million ≈ $28.68 Million	RM25.10 Million ≈ $6.30 Million	0.220x	+18.17%
2006-12-31	RM145.43 Million ≈ $36.51 Million	RM27.04 Million ≈ $6.79 Million	0.186x	--

About Duopharma Biotech Bhd

KLSE:7148 Malaysia Drug Manufacturers - Specialty & Generic

Market Cap

$309.14 Million

RM1.23 Billion MYR

Market Cap Rank

#14832 Global

#171 in Malaysia

Share Price

RM1.28

Change (1 day)

-0.78%

52-Week Range

RM1.21 - RM1.55

All Time High

RM2.86